I take 1 ug of total RNA and ribo deplete it. The leftover is usually 15 % of the total RNA. I am using reagent quantities as prescribed. May I ask how much Input you use??
Unconfigured Ad
Collapse
X
-
-
-
Hi,
I have 151 nM/ ul library concentration. I diluted it to 1nM/ul by adding 1 ul to 150 ul water. Now if I take 10 ul from this (1nM/ul) will it be equal to 10 nM/10 ul.
Or I should dilute 10nM???
Comment
-
Your desired final concentration of your library will depend on what Illumina sequencer you're using and what the facility calls for. Will you be sequencing this library yourself?
For reference, Illumina recommends storing libraries at either 2nM (HiSeq/NextSeq) or 4nM (MiSeq) and diluting to the appropriate molarity before clustering. I generally store my libraries at >10nM as I see a gradual drop in molarity over time corresponding adsorption to the plastic storage tube -- this can be mitigated by using "LoBind" tubes and adding Tween to your storage buffer.
Comment
-
Thanks, adam.geber for you reply.
Sequencing is done by Service provider and they asked me to pool the samples to 10nM for HiSeq 3000. I will consider storing the samples as suggested..
Comment
-
Definitely a good idea to store at a higher concentration than needed for submission. For reference, you'll need to redilute your 151nM library to 10nM with e.g. 5uL of your library in 70.5uL of dilution buffer or whatever volumes work best for you. Illumina recommends Tris-Cl 10*mM, pH*8.5 with 0.1% Tween 20 rather than water.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 10:52 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
||
|
Started by SEQadmin2, 10-13-2026, 09:56 AM
|
0 responses
16 views
0 reactions
|
Last Post
by SEQadmin2
10-13-2026, 09:56 AM
|
||
|
Started by SEQadmin2, 10-09-2026, 11:14 AM
|
0 responses
27 views
0 reactions
|
Last Post
by SEQadmin2
10-09-2026, 11:14 AM
|
Comment